SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-04-173160
Filing Date
2004-10-18
Accepted
2004-10-18 17:29:15
Documents
7
Period of Report
2004-10-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 23704
2 EMPLOYMENT AGREEMENT dex101.htm EX-10.1 67219
3 NOTICE OF GRANT AND INCENTIVE STOCK OPTION AGREEMENT dex102.htm EX-10.2 59264
4 NOTICE OF GRANT AND NONSTATUTORY STOCK OPTION AGREEMENT dex103.htm EX-10.3 53036
5 NOTICE OF GRANT AND RESTRICTED STOCK UNIT AGREEMENT dex104.htm EX-10.4 43035
6 CHANGE-IN-CONTROL AGREEMENT dex105.htm EX-10.5 83607
7 INDEMNIFICATION AGREEMENT dex106.htm EX-10.6 42769
  Complete submission text file 0001193125-04-173160.txt   375181
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Filer) CIK: 0001073431 (see all company filings)

IRS No.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25317 | Film No.: 041083864
SIC: 2836 Biological Products, (No Diagnostic Substances)